피리딘-2-YL-우레아
|
|
피리딘-2-YL-우레아 속성
- 녹는점
- 173 °C
- 끓는 점
- 271.2±13.0 °C(Predicted)
- 밀도
- 1.332±0.06 g/cm3(Predicted)
- 용해도
- DMSO(적게), 메탄올(약간)에 용해됨
- 물리적 상태
- 고체
- 물리적 상태
- 단단한 모양
- 산도 계수 (pKa)
- 13.69±0.70(Predicted)
- 색상
- 흰색에서 황백색까지
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
위험품 표기 | Xi,Xn | ||
---|---|---|---|
위험 카페고리 넘버 | 22-36/37/38 | ||
안전지침서 | 26 | ||
위험 참고 사항 | Irritant | ||
HS 번호 | 2933399990 |
그림문자(GHS): | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
신호 어: | Warning | |||||||||||||||||||||
유해·위험 문구: |
|
|||||||||||||||||||||
예방조치문구: |
|
피리딘-2-YL-우레아 공급 업체
글로벌( 22)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
Alchem Pharmtech,Inc. | 8485655694 |
sales@alchempharmtech.com | United States | 63711 | 58 |
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 |
sales@molcore.com | China | 49739 | 58 |
Amadis Chemical Company Limited | 571-89925085 |
sales@amadischem.com | China | 131980 | 58 |
Shanghai Sinch Parmaceuticals Tech. Co. Ltd. | +86-21-54098501 |
sales@sinch.com.cn | China | 11605 | 64 |
Wuhan Chemwish Technology Co., Ltd | 86-027-67849912 |
sales@chemwish.com | China | 35906 | 56 |
Beijing Haite lesk Technology Co., Ltd | 15210893940; 15116916250 |
chemistryliu@163.com | China | 7327 | 58 |
Shanghai Haohong Pharmaceutical Co., Ltd. | 400-8210725 4008210725 |
malulu@leyan.com | China | 39997 | 58 |
Jinan Sansanlianhe Pharmaceutical Technology Co., LTD | 70803088888 |
70803088@qq.com | China | 433 | 58 |
CHO Chemical Materials Chang Zhou CO., LTD | 15995034354 |
purchase@chochem.cn | China | 2707 | 58 |
피리딘-2-YL-우레아 관련 검색:
4,6-DIMETHYL-2-(([4-(TRIFLUOROMETHOXY)ANILINO]CARBONYL)AMINO)NICOTINAMIDE
4,6-DIMETHYL-2-(([3-(TRIFLUOROMETHYL)ANILINO]CARBONYL)AMINO)NICOTINAMIDE
3-phenyl-1-pyridin-2-yl-urea
1-(2-CHLORO-ETHYL)-3-PYRIDIN-4-YL-UREA
AURORA KA-3658
4-AMINO-1-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]-2(1H)-PYRIMIDINONE
2-(2-[3-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]-2,6-DIOXO-3,6-DIHYDRO-1(2H)-PYRIMIDINYL]ETHYL)-1H-ISOINDOLE-1,3(2H)-DIONE
N-[1-(4-CHLOROBENZYL)-2-OXO-1,2-DIHYDRO-3-PYRIDINYL]-N'-(5-METHYL-2-PYRIDINYL)UREA
1-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]-4-([3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]AMINO)-2(1H)-PYRIMIDINONE
2-[(ANILINOCARBONYL)AMINO]-4,6-DIMETHYLNICOTINAMIDE
N'-(1-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]-2-OXO-1,2-DIHYDRO-4-PYRIMIDINYL)-N,N-DIMETHYLIMINOFORMAMIDE
2-([(2-CHLOROANILINO)CARBONYL]AMINO)-4,6-DIMETHYLNICOTINAMIDE
4,6-DIMETHYL-2-[(4-TOLUIDINOCARBONYL)AMINO]NICOTINAMIDE
2-([(3-CHLOROANILINO)CARBONYL]AMINO)-4,6-DIMETHYLNICOTINAMIDE
1-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]-3-(2-PHENOXYETHYL)-2,4(1H,3H)-PYRIMIDINEDIONE
2-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]-5-[5-(([3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]AMINO)METHYL)-4,5-DIHYDRO-3-ISOXAZOLYL]-5-METHYL-1,2,4-TRIAZOLAN-3-ONE
N-(1-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]-2-OXO-1,2-DIHYDRO-4-PYRIMIDINYL)-4-METHYLBENZENESULFONAMIDE
3-BENZYL-1-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]-2,4(1H,3H)-PYRIMIDINEDIONE